About the Authors

Mark E. Sherman

Contributed equally to this work with: Mark E. Sherman, Laura Ichikawa

ShermanM@mail.nih.gov

Affiliation National Cancer Institute, Division of Cancer Prevention and Division of Cancer Epidemiology and Genetics, Bethesda, Maryland, United States of America

Laura Ichikawa

Contributed equally to this work with: Mark E. Sherman, Laura Ichikawa

Affiliation Group Health Research Institute, Group Health Cooperative, Seattle, Washington, United States of America

Ruth M. Pfeiffer

Affiliation Division of Cancer Epidemiology and Genetics, Bethesda, United States of America

Diana L. Miglioretti

Affiliations Group Health Research Institute, Group Health Cooperative, Seattle, Washington, United States of America, University of California Davis, Department of Public Health, Davis, California, United States of America

Karla Kerlikowske

Affiliation University of California San Francisco, Department of Medicine and Department of Epidemiology/Biostatistics, San Francisco, California, United States of America

Jeffery Tice

Affiliation University of California at San Francisco, Department of Medicine, San Francisco, United States of America

Pamela M. Vacek

Affiliation University of Vermont School of Medicine, Department of Medical Biostatistics, Burlington, Vermont, United States of America

Gretchen L. Gierach

Affiliation Division of Cancer Epidemiology and Genetics, Bethesda, United States of America

Competing Interests

The authors have declared that no competing interests exist.

Author Contributions

Conceptualization: MES LI RMP DLM KK JT PMV GLG. Data curation: LI DLM PMV. Formal analysis: MES LI RMP DLM.Funding acquisition: MES GLG.Investigation: MES LI RMP DLM KK JT PMV GLG. Methodology: MES LI RMP DLM.Project administration: MES LI DLM KK JT PMV.Resources: LI DLM KK JT PMV.Software: LI RMP PMV KK JT.Supervision: MES RMP DLM GLG.Visualization: MES LI.Writing – original draft: MES LI RMP DLM KK JT PMV GLG.Writing – review & editing: MES LI RMP DLM KK JT PMV GLG.